In its second partnership announced this month, Glooko is teaming with Ascensia Diabetes Care to connect the latter’s blood glucose monitoring systems to its…

Verily is joining forces with Singaporean investment company Temasek to expand its reach beyond the United States.

Johnson & Johnson is pondering what to do next with its diabetes device subsidiaries Animas, LifeScan and Calibra Medical.

Atlas Genetics has raised $35 million to trial and commercialize a 30-minute test for chlamydia and gonorrhea.

Biogen is joining forces with Siemens Healthineers to develop MRI applications to quantify “key markers” indicating multiple sclerosis activity and progression.

Bio-Rad has kicked off 2017 with a bang, announcing it has inked a deal to acquire genetic analysis player RainDance Technologies for an undisclosed amount.

Johnson & Johnson’s DePuy Synthes Products is collaborating with Orthocell on development of a stem cell-based approach to the regeneration of tendons.

Efferent Labs has inked a deal with Evotec to develop implantable biosensor technology. The device contains living cells to measure cellular function in vivo.

One year ago, Illumina announced it was teaming up with Bio-Rad Laboratories to develop a next-generation sequencing solution for single-cell analysis. The…

OxSonics and its sister company have raised $11 million to take ultrasound-based technologies into clinical development.